Charles Nichols
12PUBLICATIONS
19CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (12)
Sort by Publication Date:
|Nov 04, 2026
Next-Generation Psychedelic Drug Development.|Nov 12, 2025
Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.Hannah M Kramer, Meghan Hibicke, Jason Middleton
|Jun 19, 2025
The Selective Serotonin 5‑HT2A Receptor Agonist (S)‑3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.Anders A Jensen, Claudia R Cecchi, Meghan Hibicke
|Feb 15, 2024
Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression.Thomas W Flanagan, Timothy P Foster, Thomas E Galbato
|Feb 22, 2023
Conditioned place avoidance is associated with a distinct hippocampal phenotype, partly preserved pattern separation, and reduced reactive oxygen species production after stress.D Parker Kelley, Lucas Albrechet-Souza, Shealan Cruise
|Jun 14, 2022
Preface to the special issue "Psychedelics and Neurochemistry".Charles D Nichols, David E Nichols
Pageof 2
Frequent Collaborators
2 joint publications
Meghan Hibicke
2 joint publications
D Parker Kelley
1 joint publications
Anders A Jensen
1 joint publications
Emil Märcher-Rørsted
1 joint publications
Jesper L Kristensen
1 joint publications
Matthew W Johnson
1 joint publications
Kevin S Murnane
1 joint publications
Mark M Rasenick
1 joint publications
Urszula Kozlowska
1 joint publications
Kalina Wiatr